Patent · US Active

Rapid-acting insulin compositions

US9439952B2 · kind B2 · utility

8Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2015
Grant dateSep 13, 2016
Priority date
Expiry dateMay 4, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is a composition of human insulin or insulin analog that includes treprostinil and that has faster pharmacokinetic action than commercial formulations of existing insulin analog products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.